Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

LUMA Vision

Request full access

We enable Cardiologists to save lives through exceptional decision-making accuracy

Dublin, IrelandFounded 2017Biotech & Life Sciences

About LUMA Vision

Developer of connected intra-vascular medical devices designed to help facilitate the treatment of cardiac arrhythmia. The company utilizes artificial intelligence (AI) and real-time tissue analysis through advanced four-dimensional imaging and improves the way EP and structural heart interventions are treated, enabling doctors to perform cardiac treatments that improve outcomes for patients, increase procedural safety and reduce the cost to the healthcare system.

Source: Dealroom company data

At a glance

Status
Operational
Employees
78
Open positions
None listed
Dealroom signal
72.7/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices, Health Platform
Sector
Biotechnology, Cardiology and cardiovascular, Medical Data Systems, Medical Imaging
Technology
Artificial Intelligence, Hardware, Big Data, Deep Tech
Business model
Manufacturing
Client focus
B2B

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Dec 2025 $0 — Enterprise Ireland —
GRANTOther financing Dec 2023 $6M — Enterprise Ireland ↗
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

LUMA Vision website traffic

Latest recorded traffic for LUMA Vision is 3.3K monthly website visits, up 153.8% over the last three months. LUMA Vision's team grew 2.6% over the past year.

Latest monthly visits3.3K 3-month web change+153.8% 1-year team growth+2.6%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

LUMA Vision in the Dublin ecosystem

Live from Dealroom

The LUMA Vision office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • European Innovation Council
  • Disruptive Technologies Innovation Fund

Series A7 investors entered at this stage

  • EIC Fund
  • EQT Life Sciences
  • Atlantic Bridge University Fund
  • Enterprise Ireland
  • imec.xpand
  • Atlantic Bridge
  • Bayern Kapital

Other known investors3 additional known investors

  • Trinity College Dublin
  • EIT Health
  • University of Galway
Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See LUMA Vision’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.